# Eric Levin

> Eric Levin is the co-founder and CEO of Scripta Insights, a Needham, Massachusetts healthcare technology company that helps self-insured employers and health plans cut prescription drug costs by flagging clinically equivalent, lower-cost medication alternatives. A serial entrepreneur who has managed products with more than $5 billion in cumulative sales and been part of 32-plus mergers and acquisitions, Levin previously helped grow The Learning Company alongside Kevin O'Leary into a business that sold for $3.6 billion. Since taking the CEO seat at Scripta in 2017, he has positioned the company as an unbiased transparency layer over the opaque pharmacy benefits industry, growing it to 80-plus clients and $42 million in total funding.

- **Role:** Co-Founder & CEO at Scripta Insights
- **Organizations:** Scripta Insights, The Learning Company, Mattel, Li & Fung Ltd., Techno Source, Frictionless Commerce, M5 Consulting, Inc.
- **Nationality:** American
- **Education:** BS in Business Administration, dual majors in Marketing & Accounting, Babson College, Executive education, Columbia Business School
- **Known for:** Grew The Learning Company (with Kevin O'Leary's team) from $60M to over $1.2B in sales, leading to a $3.6B exit, Managed or created products with cumulative sales in excess of $5 billion, Involved in more than 32 mergers and acquisitions

## Career timeline

- **1991** — Graduated from Babson College with a BS in Business Administration
- **1990s** — Joined Kevin O'Leary's team, helping grow The Learning Company from $60M to over $1.2B in sales, culminating in a $3.6B sale
- **2000s** — Held senior roles including SVP at Mattel, CMO at Frictionless Commerce, and CEO & Co-President at Techno Source
- **2010s** — Served as Division President and Corporate SVP at Li & Fung Ltd., a ~$20B global company, and CEO of M5 Consulting
- **2017** — Became Co-Founder & CEO of Scripta Insights
- **2019** — Publicly launched Scripta Insights, positioning it against the $300B pharmacy benefits industry
- **2024** — Led Scripta to 100%+ revenue growth; 78,000 prescription switches produced $29M in member savings
- **2024** — Closed $17M Series B led by Aquiline Capital Partners, bringing total funding to $42M

## Achievements

- Grew The Learning Company (with Kevin O'Leary's team) from $60M to over $1.2B in sales, leading to a $3.6B exit
- Managed or created products with cumulative sales in excess of $5 billion
- Involved in more than 32 mergers and acquisitions
- Led Scripta Insights to 80+ clients and $42M in total funding
- Drove 78,000 prescription switches producing $29M in savings in a single year, with 93% of switches sticking after 12 months

## Latest updates

- **2024-12** — Scripta Insights closed a $17M Series B led by Aquiline Capital Partners, bringing total funding to $42M.
- **2024** — Company reported 100%+ revenue growth and $29M in member prescription savings over the year.

## Links

- Website: https://scriptainsights.com
- LinkedIn: https://www.linkedin.com/in/eric-levin-048138/
- Twitter/X: https://twitter.com/scriptainsights
- Facebook: https://facebook.com/scriptainsights

---

Profile page: https://yespress.io/eric-levin
Published by YesPress — https://yespress.io
Last updated: 2026-07-17